Literature DB >> 35013773

Cellular dissociation: a missing item in the pathology report and histologic grading of oral tongue cancer?

Alhadi Almangush1,2,3,4, Antti A Mäkitie5,6,7, Ilmo Leivo8,9.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35013773     DOI： 10.1007/s00428-022-03270-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.535


× No keyword cloud information.
  9 in total

1.  Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.

Authors:  Aditi Arora; Nuzhat Husain; Ankur Bansal; Azfar Neyaz; Ritika Jaiswal; Kavitha Jain; Arun Chaturvedi; Nidhi Anand; Kiranpreet Malhotra; Saumya Shukla
Journal:  Am J Surg Pathol       Date:  2017-07       Impact factor: 6.394

2.  Association between pathological invasion patterns and late lymph node metastases in patients with surgically treated clinical No early oral tongue carcinoma.

Authors:  Yukiko Hori; Akira Kubota; Tomoyuki Yokose; Madoka Furukawa; Takeshi Matsushita; Nobuhiko Oridate
Journal:  Head Neck       Date:  2019-10-24       Impact factor: 3.147

3.  A Proposal to Revise the Histopathologic Grading System of Early Oral Tongue Cancer Incorporating Tumor Budding.

Authors:  Amr Elseragy; Tuula Salo; Ricardo D Coletta; Luiz P Kowalski; Caj Haglund; Pentti Nieminen; Antti A Mäkitie; Ilmo Leivo; Alhadi Almangush
Journal:  Am J Surg Pathol       Date:  2019-05       Impact factor: 6.394

4.  Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system.

Authors:  Melanie Boxberg; Moritz Jesinghaus; Christiane Dorfner; Carolin Mogler; Enken Drecoll; Arne Warth; Katja Steiger; Christine Bollwein; Petra Meyer; Klaus D Wolff; Andreas Kolk; Wilko Weichert
Journal:  Histopathology       Date:  2017-03-28       Impact factor: 5.087

5.  The prognostic role of histologic grade, worst pattern of invasion, and tumor budding in early oral tongue squamous cell carcinoma: a comparative study.

Authors:  Bin Xu; Abeer M Salama; Cristina Valero; Avery Yuan; Anjanie Khimraj; Maelle Saliba; Daniella K Zanoni; Ian Ganly; Snehal G Patel; Nora Katabi; Ronald Ghossein
Journal:  Virchows Arch       Date:  2021-03-04       Impact factor: 4.535

6.  Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion.

Authors:  Shota Shimizu; Akihiro Miyazaki; Tomoko Sonoda; Kazushige Koike; Kazuhiro Ogi; Jun-Ichi Kobayashi; Takeshi Kaneko; Tomohiro Igarashi; Megumi Ueda; Hironari Dehari; Akira Miyakawa; Tadashi Hasegawa; Hiroyoshi Hiratsuka
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

7.  Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: a Web-based prognostic tool.

Authors:  Rasheed Omobolaji Alabi; Mohammed Elmusrati; Iris Sawazaki-Calone; Luiz Paulo Kowalski; Caj Haglund; Ricardo D Coletta; Antti A Mäkitie; Tuula Salo; Ilmo Leivo; Alhadi Almangush
Journal:  Virchows Arch       Date:  2019-08-17       Impact factor: 4.064

8.  Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma.

Authors:  Wilko Weichert; Melanie Boxberg; Moritz Jesinghaus; Katja Steiger; Fabian Stögbauer; Bernhard Haller; Andreas Kolk; Ulrich Straßen; Anja Pickhard; Markus Wirth; Miguel Silva; Jan Budczies; Aaron Becker von Rose; Björn Konukiewitz; Peer Kuhn; Konrad Klinghammer; Hendrik Dapper; Stefan Münch; Stephanie E Combs
Journal:  Br J Cancer       Date:  2020-01-15       Impact factor: 7.640

9.  Tumour budding in oral squamous cell carcinoma: a meta-analysis.

Authors:  Alhadi Almangush; Matti Pirinen; Ilkka Heikkinen; Antti A Mäkitie; Tuula Salo; Ilmo Leivo
Journal:  Br J Cancer       Date:  2017-11-30       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.